ATA and Endocrine Sister Societies urge FDA to consider expert opinion and the health of…
Read More
ATA, AACE and TES respond to FDA postponement of workshop March 19, 2004 Steven Galson,…
FDA Bioequivalence Workshop Plans continue with ATA, Endocrine Society and AACE leaders 2003-2004 President Clark…
Draft Levothyroxine Workshop Agenda Download Agenda (PDF File, 108 KB) See related articles on Bioequivalence…
FDA invites ATA, TES & AACE to Plan Workshop on Thyroxine Bioequivalence # # #…
ATA Continues Dialog With FDA on Levothyroxine Dose Precision and Bioequivalence Standards 2003-2004 President Clark…
ATA asks the FDA to ensure safe and effective levothyroxine preparations April 4, 2003 Mark…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.